Not Signed In - Main Topic Area
Clinical Trials
1 - 5 of 36 more >>
- ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
Cardiovascular Diseases
- The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial
ClinicalTrials.gov Identifier: NCT00095654 - Active, not recruiting
Impaired Glucose Tolerance; Cardiovascular Disease; Glucose Metabolism Disorders
- The Study of Atherosclerosis with Ramipril and Rosiglitazone
ClinicalTrials.gov Identifier: NCT00140647 - Active, not recruiting
Atherosclerosis; Impaired Glucose Tolerance; isolated impaired fasting glucose; Cardiovascular Disease
- A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
ClinicalTrials.gov Identifier: NCT00368277 - Active, not recruiting
Hypertension
- Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
ClinicalTrials.gov Identifier: NCT00574834 - Recruiting
Metabolic Syndrome
email this page
print this page
bookmark this page
feedback on this page
